Brokers Set Expectations for Varian Medical Systems, Inc.’s Q4 2017 Earnings (VAR)

Varian Medical Systems, Inc. (NYSE:VAR) – Analysts at Barrington Research boosted their Q4 2017 earnings per share (EPS) estimates for shares of Varian Medical Systems in a research note issued to investors on Thursday. Barrington Research analyst M. Petusky now expects that the medical equipment provider will post earnings per share of $1.17 for the quarter, up from their prior forecast of $1.12. Barrington Research has a “Market Perform” rating on the stock.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.09. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. The company had revenue of $662.40 million during the quarter, compared to analyst estimates of $663.86 million. During the same quarter in the previous year, the business earned $1.00 EPS. The firm’s revenue was up 3.0% on a year-over-year basis. ILLEGAL ACTIVITY WARNING: “Brokers Set Expectations for Varian Medical Systems, Inc.’s Q4 2017 Earnings (VAR)” was originally reported by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.com-unik.info/2017/08/19/brokers-set-expectations-for-varian-medical-systems-inc-s-q4-2017-earnings-var-updated-updated.html.

VAR has been the subject of a number of other research reports. BidaskClub downgraded shares of Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Off Wall Street initiated coverage on shares of Varian Medical Systems in a research note on Monday, April 24th. They set a “sell” rating for the company. Zacks Investment Research raised shares of Varian Medical Systems from a “strong sell” rating to a “hold” rating in a research note on Thursday, April 6th. Citigroup Inc. raised shares of Varian Medical Systems from a “neutral” rating to a “buy” rating in a research note on Monday, May 15th. Finally, Jefferies Group LLC reissued a “buy” rating on shares of Varian Medical Systems in a research note on Thursday, May 11th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $96.28.

Shares of Varian Medical Systems (NYSE VAR) traded up 0.85% during trading on Monday, hitting $97.95. 292,138 shares of the stock traded hands. The firm has a 50-day moving average of $103.33 and a 200-day moving average of $92.52. Varian Medical Systems has a 1-year low of $75.20 and a 1-year high of $107.08. The firm has a market capitalization of $8.98 billion, a price-to-earnings ratio of 32.24 and a beta of 0.62.

In other news, Director Timothy E. Guertin sold 16,000 shares of Varian Medical Systems stock in a transaction dated Friday, June 9th. The shares were sold at an average price of $103.22, for a total transaction of $1,651,520.00. Following the completion of the transaction, the director now directly owns 2,161 shares in the company, valued at $223,058.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Kolleen T. Kennedy sold 26,092 shares of Varian Medical Systems stock in a transaction dated Tuesday, June 20th. The shares were sold at an average price of $105.00, for a total transaction of $2,739,660.00. Following the transaction, the executive vice president now owns 52,692 shares of the company’s stock, valued at $5,532,660. The disclosure for this sale can be found here. Insiders sold 144,087 shares of company stock valued at $14,652,328 over the last 90 days. Corporate insiders own 0.91% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of VAR. First Mercantile Trust Co. boosted its position in shares of Varian Medical Systems by 2.3% in the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock worth $100,000 after buying an additional 25 shares in the last quarter. Parallel Advisors LLC boosted its position in shares of Varian Medical Systems by 16.7% in the first quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock worth $113,000 after buying an additional 176 shares in the last quarter. Heritage Trust Co acquired a new position in shares of Varian Medical Systems during the first quarter worth about $118,000. Penserra Capital Management LLC boosted its position in shares of Varian Medical Systems by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,610 shares of the medical equipment provider’s stock worth $146,000 after buying an additional 140 shares in the last quarter. Finally, Pacer Advisors Inc. boosted its position in shares of Varian Medical Systems by 3.1% in the first quarter. Pacer Advisors Inc. now owns 1,815 shares of the medical equipment provider’s stock worth $165,000 after buying an additional 55 shares in the last quarter. Hedge funds and other institutional investors own 99.64% of the company’s stock.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Earnings History and Estimates for Varian Medical Systems (NYSE:VAR)

What are top analysts saying about Varian Medical Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Varian Medical Systems Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit